Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2022 05:00 ET | Source: Beta Bionics, Inc.

Pivotal Trial Results of the iLet® Bionic Pancreas to Be Presented at the ADA’s 82nd Scientific Sessions

Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Dr. Roy W. Beck will moderate a session: The...
May 10, 2022 05:00 ET | Source: Beta Bionics, Inc.

Beta Bionics Appoints Gilad Glick to the Board of Directors and Veena Rao, Ph.D. as Chief Commercial Officer

Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Gilad Glick, former Chief Executive Officer,...
April 30, 2022 04:00 ET | Source: Beta Bionics, Inc.

The iLet® Bionic Pancreas Significantly Reduced HbA1c and Improved Time in Range vs Standard of Care for a Diverse Range of People with Type 1 Diabetes

The trial achieved key primary and secondary endpoints, demonstrating improved outcomes over standard of care for people living with type 1 diabetes.The study population — 440 adults and children 6...
April 25, 2022 05:00 ET | Source: Beta Bionics, Inc.

Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD

Dr. Steven J. Russell will present the results from the multi-center randomized Insulin-Only Bionic Pancreas Pivotal Trial at the International Conference on Advanced Technologies & Treatments for...
March 02, 2022 16:15 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Executive Leadership and Board Transitions in Preparation for Commercialization of the iLet® Bionic Pancreas System

Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. Dr. Ed Damiano, President & CEO of Beta...
February 17, 2022 16:00 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Closing of $57 Million Series C Financing

Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not available for sale. The financing round was co-led by existing...
December 22, 2021 07:00 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Data Lock of the Insulin-Only Bionic Pancreas Pivotal Trial and Enrollment into the Screening Protocol of the Bihormonal Bionic Pancreas Pivotal Trial

The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use.Not available for sale. The iLet® Bionic Pancreas is a pocket-sized, wearable...
May 06, 2021 16:00 ET | Source: Beta Bionics, Inc.

Beta Bionics Announces Appointment of Christy Jones to Board of Directors

IRVINE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a medical technology company focused on the design, development, and commercialization of the iLet® bionic pancreas system, today...